Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 3Hypogonadism 2Osteoporosis 1Neoplasms 1Neoplasm Metastasis 1Genetic Diseases, Inborn 1

Interventions

Zoledronic Acid 5bicalutamide 2Resistance Training 2Nutrition Assessment 2Goserelin 2Cholecalciferol 2Calcium 2Absorptiometry, Photon 2Vitamin D 1Toremifene 1Risedronic Acid 1Radiotherapy 1Lysine Acetyltransferase 5 1Gonadotropin-Releasing Hormone 1Estrogen Antagonists 1Estradiol 1Denosumab 1Calcium Gluconate 1Calcium Carbonate 1Blood Specimen Collection 1Alendronate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteoporosis × Alendronate × Genitourinary × Clear all
NCT00048841 2010-03-02

Prevention of Osteoporosis in Men With Prostate Cancer

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Phase 3 Completed
112 enrolled
Genitourinary

Hypogonadism, Osteoporosis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡